TY - JOUR
T1 - Quality of Life Questionnaires in Breast Cancer-Related Lymphedema Patients
T2 - Review of the Literature
AU - Cornelissen, Anouk J. M.
AU - Kool, Melissa
AU - Keuter, Xavier H. A.
AU - Heuts, Esther M.
AU - de Grzymala, Andrzej A. Piatkowski
AU - van der Hulst, Rene R. W. J.
AU - Qiu, Shan Shan
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Purpose: Lymphedema of the arm is one of the most common and underestimated side effects of breast cancer treatment. It is known to negatively affect the quality of life (QoL) in breast cancer survivors. However, there are multiple questionnaires used to measure QoL in lymphedema patients. The current study aimed to determine the most complete and accurate questionnaire. Methods: A systematic literature search in Cochrane Library database CENTRAL, MEDLINE, and EMBASE was conducted in August 2016 by two independent researchers. The strategy used for the search was: ((Lymphedema[Mesh]) AND (Quality of life[Mesh])). All QoL questionnaires for patients with breast cancer-related lymphedema (BCRL) were included. An overview of the assessed QoL domains and arm symptom-specific questions was made, to assess the most complete and accurate questionnaire. Results: A total of 142 studies were identified, of which 49 met the inclusion criteria and 15 different questionnaires were extracted. The Lymphedema Quality of Life Inventory (LyQLI), assesses all QoL domains, except for the possibility of wearing the clothes of choice, and assess all specific arm symptoms. The Lymphedema Functioning, Disability, and Health (Lymph-ICF) Questionnaire assesses all QoL domains, except for sexual functioning, and does assess all specific arm symptoms. Conclusion: According to the results obtained, the LyQLI and Lymph-ICF questionnaires were the two most complete and accurate questionnaires to assess QoL in patients with BCRL, because these questionnaires assess the largest number of QoL domains and specific arm symptoms.
AB - Purpose: Lymphedema of the arm is one of the most common and underestimated side effects of breast cancer treatment. It is known to negatively affect the quality of life (QoL) in breast cancer survivors. However, there are multiple questionnaires used to measure QoL in lymphedema patients. The current study aimed to determine the most complete and accurate questionnaire. Methods: A systematic literature search in Cochrane Library database CENTRAL, MEDLINE, and EMBASE was conducted in August 2016 by two independent researchers. The strategy used for the search was: ((Lymphedema[Mesh]) AND (Quality of life[Mesh])). All QoL questionnaires for patients with breast cancer-related lymphedema (BCRL) were included. An overview of the assessed QoL domains and arm symptom-specific questions was made, to assess the most complete and accurate questionnaire. Results: A total of 142 studies were identified, of which 49 met the inclusion criteria and 15 different questionnaires were extracted. The Lymphedema Quality of Life Inventory (LyQLI), assesses all QoL domains, except for the possibility of wearing the clothes of choice, and assess all specific arm symptoms. The Lymphedema Functioning, Disability, and Health (Lymph-ICF) Questionnaire assesses all QoL domains, except for sexual functioning, and does assess all specific arm symptoms. Conclusion: According to the results obtained, the LyQLI and Lymph-ICF questionnaires were the two most complete and accurate questionnaires to assess QoL in patients with BCRL, because these questionnaires assess the largest number of QoL domains and specific arm symptoms.
KW - breast cancer
KW - lymphedema
KW - quality of life
KW - questionnaire
KW - UPPER-EXTREMITY LYMPHEDEMA
KW - EUROPEAN ORGANIZATION
KW - OUTCOME MEASURE
KW - ARM
KW - VALIDATION
KW - VALIDITY
KW - IMPACT
KW - WOMEN
KW - RELIABILITY
KW - MORBIDITY
U2 - 10.1089/lrb.2017.0046
DO - 10.1089/lrb.2017.0046
M3 - (Systematic) Review article
C2 - 29437542
SN - 1539-6851
VL - 16
SP - 134
EP - 139
JO - Lymphatic Research and Biology
JF - Lymphatic Research and Biology
IS - 2
ER -